Patent Baristas

The U.S. Court of Appeals for the Federal Circuit gave a high-five to settlement agreements between a patent holder and a generic manufacturer saying it doesn’t violate antitrust laws under the Hatch-Waxman Act.  In re Ciprofloxacin Hydrochloride Antitrust Litigation (08-1097). The agreements in question involved a reverse payment from the Bayer to Barr, but did […]

The Court of Appeals for the Federal Circuit handed down the long awaited en banc decision on In re Bilski (07-1130) in which the court looked at the question of when does a claim that contains both mental and physical steps create patent-eligible subject matter and whether a method or process must result in a […]

According to biotechTransfer week, the IRS set to look over the financial statements of public and private colleges and universities for unrelated income sources like tech transfer. The Internal Revenue Service is looking to gather information from hundreds of US colleges, universities, and affiliated organizations such as foundations and academic medical centers about their financial […]

John J. Doll, Commissioner for Patents, US Patent & Trademark Office, talked today at the BIO Intellectual Property Counsel Committee’s Fall Conference and Committee Meeting, a group with a very keen sense of the importance of patents. He livened up the discussion in extolling that “We [the Patent Office] don’t have a standard so we’d […]

In a session on Case Law Updates, a panel discussion at the the BIO Intellectual Property Counsel Committee’s Fall Conference and Committee Meeting brought up that there was previously a lot of attention on infringement but lately it has been off radar except for joint joint infringement. Joint infringement comes up as a big issue […]

In a session on Case Law Updates at the the BIO Intellectual Property Counsel Committee’s Fall Conference and Committee Meeting, Chad Shear led a panel discussion with John Dragseth and Dr. John Garvish through a discussion of Bilski and how we got to Bilski.  The case, involved a patent application seeking exclusive rights to a […]

Editor-in-Chief Barista, Stephen Jenei, will be live-blogging the BIO Intellectual Property Counsel Committee’s Fall Conference and Committee Meeting on Oct. 20-22, 2008, at the Hard Rock Hotel at Universal Orlando, Orlando, Florida. The Conference should be an excellent opportunity for BIO members to hear, listen, and learn about current and projected topics related to biotechnology […]

It’s a well-known fact that drug industries pursue patents with a zeal that few possess – after all, a patent in the hand is worth millions in the bank and a relative monopoly over the pharmaceutical market. They lobby for political support to push these patents through, even if they know that the drugs have […]